In a sensitivity analysis where we excluded patients with antipsychotic treatment, the significant negative association between CSF GH concentrations and bipolar disorder remained in the SBP-S (β = −0.57, p = 0.019), but was no longer significant in the SBP-G (β = −0.43, p = 0.209) (Supplementary table 6). The gene discussed is GH1; the disease is bipolar disorder.